CompletedNot Applicable

Telemedicine in High-Risk Cardiovascular Patients Post-ACS

United Kingdom337 participantsStarted 2022-01-06

Plain-language summary

This is a non-CTIMP randomised controlled trial looking at the utilisation of telemedicine devices to provide remote, clinically necessary, diagnostic information, without the need for hospital attendance that patients will take home with them following admission to hospital with a heart attack.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 1 ACS Patients diagnosed with elevated hs-cTnI I who have undergone coronary intervention for NSTEMI or STEMI or unstable angina. * 2 In addition, the participant should have at least one additional cardiovascular risk factor: * Current or ex-Tobacco Use * Hypertension * Diabetes * Hypercholesterolaemia. * Male aged \> 50 years. * 3 Access to a smartphone or smart device. Exclusion Criteria: * 1 The inability to apply/use the telemonitoring equipmentt * 2 Life expectancy of 9 months or less.

What they're measuring

Number of Participants With Hospital Readmission at 6 Months

Timeframe: 6 months

Emergency Department Visits at 6 Months

Timeframe: 6 Months

Trial details

NCT IDNCT05015634

SponsorImperial College London

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-28

Results submitted2025-12-08

View on ClinicalTrials.gov More Cardiovascular Diseases trials